Hyperliquid Strategies completes business combination with Sonnet BioTherapeutics

Go back to Hyperliquid Strategies completes business combination with Sonnet BioTherapeutics
(NASDAQ: PURR) Delayed: 9.85 +0.78 (8.60%)
Previous Close $9.07    52 Week High $ 
Open $9.17    52 Week Low $ 
Day High $10.07    P/E N/A 
Day Low $9.17    EPS $ 
Volume 11,156,050       

(NASDAQ: SONN) Delayed: 1.26 --0 (-0%)
Previous Close $1.26    52 Week High $ 
Open $1.26    52 Week Low $ 
Day High $1.26    P/E N/A 
Day Low $1.26    EPS $ 
Volume 1,462